How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Patients Repositioning Offloading Device Market
- By Product Type: Total Contact Casts, Removable Cast Walkers, Post-Operative Shoes, Therapeutic Footwear, Heel Offloading Devices
- By Material: Plaster of Paris, Fiberglass, Thermoplastics, EVA Foam, Neoprene
- By Application: Diabetic Foot Ulcers, Pressure Ulcers, Post-Surgical Offloading, Charcot Foot, Venous Leg Ulcers
- By End User: Hospitals, Specialty Clinics, Home Healthcare Settings, Orthopedic Centers, Wound Care Centers
- By Patient Age Group: Pediatric, Adult, Geriatric
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Total Contact Casts leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Patients Repositioning Offloading Device Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Material 5
Application 5
End User 5
Patient Age Group 3
Companies profiled
Stryker Corporation
Hill-Rom Holdings
Inc. (a Baxter International company)
Medline Industries Inc.
Drive DeVilbiss Healthcare
Arjo AB
Invacare Corporation
Joerns Healthcare LLC
Span-America Medical Systems Inc.
Molnlycke Health Care
Cardinal Health Inc.
Paramount Bed Co. Ltd.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Hill-Rom Holdings
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Inc. (a Baxter International company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Medline Industries Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Drive DeVilbiss Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Arjo AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Invacare Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Joerns Healthcare LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Span-America Medical Systems Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Molnlycke Health Care
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cardinal Health Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Paramount Bed Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Sunrise Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →KCI Medical (an Acelity company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Biodex Medical Systems Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →BHM Medical
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,278M by 2033 · 10.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Total Contact Casts30.1
- Removable Cast Walkers22.5
- Post-Operative Shoes16.4
- Therapeutic Footwear10.5
- Heel Offloading Devices20.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$618.1M → $1,345M · 10.2%
Europe$430.8M → $1,006M · 11.2%
Asia Pacific$393.3M → $840.6M · 10.0%
Latin America$243.5M → $502.9M · 9.5%
Middle East and Africa$187.3M → $477.5M · 12.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.832026
10.832027
10.862028
10.862029
10.872030
10.882031
10.902032
10.912033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Stryker Corporation17.1
- Hill-Rom Holdings23.0
- Inc. (a Baxter International company)4.4
- Medline Industries Inc.10.4
- Drive DeVilbiss Healthcare11.2
- Arjo AB5.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type27.2%
Material22.8%
Application11.3%
End User28.2%
Patient Age Group10.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.2
- Europe24.1
- Asia Pacific20.2
- Latin America12.1
- Middle East and Africa11.4
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Stryker Corporation | 98 | 91 | 87 | 98 | 96 | 87 | 93 |
| Hill-Rom Holdings | 82 | 80 | 79 | 72 | 88 | 68 | 78 |
| Inc. (a Baxter International company) | 67 | 75 | 68 | 87 | 86 | 75 | 76 |
| Medline Industries Inc. | 64 | 76 | 75 | 68 | 59 | 66 | 68 |
| Drive DeVilbiss Healthcare | 76 | 76 | 68 | 72 | 66 | 54 | 69 |
| Arjo AB | 46 | 66 | 48 | 49 | 61 | 54 | 54 |
| Invacare Corporation | 63 | 57 | 49 | 41 | 62 | 50 | 54 |
| Joerns Healthcare LLC | 47 | 52 | 45 | 55 | 43 | 48 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Stryker Corporation
- Hill-Rom Holdings
- Inc. (a Baxter International company)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Stryker Corporation | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Hill-Rom Holdings | ◐ | ✓ | ◐ | ◐ | ◐ | ✓ |
| Inc. (a Baxter International company) | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Medline Industries Inc. | ◐ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Drive DeVilbiss Healthcare | ◐ | ◐ | ◐ | ◐ | ✓ | − |
| Arjo AB | − | ◐ | − | − | ◐ | ◐ |
| Invacare Corporation | ◐ | ◐ | − | ◐ | ◐ | − |
| Joerns Healthcare LLC | ◐ | − | ◐ | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Stryker Corporation93
2Hill-Rom Holdings78
3Inc. (a Baxter International company)76
4Drive DeVilbiss Healthcare69
5Medline Industries Inc.68
6Arjo AB54
7Invacare Corporation54
8Joerns Healthcare LLC48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Stryker CorporationHill-Rom Holdings
Challenger3
Strong scale, closing on the leaders.
Inc. (a Baxter International company)Medline Industries Inc.Drive DeVilbiss Healthcare
Niche3
Specialists in a single segment or region.
Arjo ABInvacare CorporationJoerns Healthcare LLC
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Patients Repositioning Offloading Device Market — a $424M beachhead inside a $5.94B market.
Beachhead (SOM)$424Mobtainable near-term
Serviceable (SAM)$2.47Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Total Contact Casts
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
Removable Cast Walkers
Strong fit — clear ROI and a fast path to value.
End user65 fit
Post-Operative Shoes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel30%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Patients Repositioning Offloading Device Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified23%
Evaluation12%
Closed-won7%
$16.7KCAC
$71KLTV
4.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Patients Repositioning Offloading Device Market is a durable-growth opportunity — $4.27B by 2033, compounding at 9.8%.
TAM · 2025$2.02Btoday
TAM · 2033$4.27Bforecast
CAGR9.8%2027–2033
Cumulative$27.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.27BTotal addressable market
SAM$1.66BServiceable available market
SOM$318MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.8% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.27BLarge & growingTAM by 2033 at 9.8% CAGR
$1.66BServiceable nowreachable with today’s model
$318MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.33BBear6.4% CAGR
$4.27BBase9.8% CAGR
$5.46BBull12.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Patients Repositioning Offloading Device Market — a $2.47B market by 2033. Plan: grow share from 8.4% to 13.2%.
Market size · 2033$2.47Btotal addressable
Market CAGR10.7%2027–2033
Target share13.2%from 8.4% today
Revenue ambition$326Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.4% | 13.2% | Behind |
| Revenue | $225M | $326M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 32.3% | 43.1% | Ahead |
| Customer retention | 89.0% | 93.5% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Material capability
A defensible second engine — invest in Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $44M capacity & capability investment
- Greenlight bolt-on M&A in Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeBehind
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Patients Repositioning Offloading Device Market conversation — a $3.48B market you can size, segment and defend in minutes.
Market size · 2033$3.48Btotal opportunity
Growth4.3%CAGR to 2033
Addressable buyers1,386+accounts in scope
Typical ROI4.8×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.8×return on cost, year one
< 2 mopayback period
$41K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Stryker CorporationHill-Rom HoldingsInc. (a Baxter International company)Medline Industries Inc.Drive DeVilbiss HealthcareArjo ABInvacare CorporationJoerns Healthcare LLC+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Patients Repositioning Offloading Device Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Patients Repositioning Offloading Device Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Patient-specific Cranial Implant Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportPatient-side R/F System Market
Market size, share, segmentation and regional forecast.
$674M market · 2025 base year
View reportPatient Self-service Kiosk Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportPatient Safety and Risk Management Solutions Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportPatient Room Recliners Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportPatient Room Cabinets Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportPatient Room Armchairs Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportPatient Return Electrodes (Dispersive Electrodes) Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportPatient Remote Monitoring Systems Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportPatient Relationship Management Software Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportPatient Registration Software Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportPatient Referral Software Market
Market size, share, segmentation and regional forecast.
$886M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.